Concurrently, AKT signaling induces chemokines such as CCL2, promoting the recruitment of immunosuppressive cells like tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs) (27). The gene discussed is CCL2; the disease is neoplasm.